EUVIMED · CrossrefZeitschrift
Journal of Thrombosis and Haemostasis
ISSN 1538-7836 · Elsevier BV
Neueste Artikel
Unmasking the link: pulmonary embolism risk and outcomes in adults with immune thrombocytopenia
Shear cytokine crosstalk is a determinant of SARS-CoV-2–induced endothelial pathophysiology and thrombosis in human vessel chips
Direct glycoprotein-specific platelet autoantibodies detected in a majority of patients with persistent chemotherapy-induced thrombocytopenia
Enoxaparin for the treatment of placenta-derived fetal growth restriction (GROWTH): an open-label multicenter randomized trial
Immune parameters correlate with fibrinolysis and predict efficacy of ultrasound-assisted catheter-directed thrombolysis in acute pulmonary embolism
Acute stress activates Piezo1 to drive neutrophil extracellular traps formation and aggravated arterial thrombosis
Heparin re-exposure in patients with a history of heparin-induced thrombocytopenia
Prevalence and thrombotic risk of platelet factor 4–dependent platelet-activating antibodies
Socioeconomic status and its association with venous thromboembolism during pregnancy and postpartum: results from a Dutch population-based study
Use of factor concentrates for the management of perioperative bleeding: guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis
Pharmacology of anticoagulants: from heparin to novel target-specific agents
Comparison of the effects of abelacimab, asundexian, and milvexian on medical device-induced clotting and thrombin generation in vitro
The body fights back—inflammation in acute pulmonary embolism
Characterization of a series of patients with GNE-related thrombocytopenia: insights into pathogenesis, diagnosis, and treatment
False-negative immunoassays in heparin induced thrombocytopenia
Autosomal dominant thrombocytopenia caused by a heterozygous CYCS variant: a new family and literature review
Pulmonary embolism in immune thrombocytopenia: insights from a contemporary cohort
It is time to accept the painful truth: low-molecular-weight heparin does not improve outcomes in women with pregnancy complications
Multimodal management of refractory gastrointestinal bleeding in myeloma-associated acquired von Willebrand syndrome: a role for emicizumab prophylaxis
Factor IX gene variants may influence the pharmacokinetic profile of patients with hemophilia B treated with Factor IX-fusion protein or N9-GP extended half-life Factor IX concentrates
Clinical implications of ADAMTS-13 conformation ELISA in immune-mediated thrombotic thrombocytopenic purpura with undetectable ADAMTS-13 antigen
Nonhemostatic platelet-dependent protection against murine bacterial pneumonia
The tissue factor-TFPI pathway as a therapeutic target in bleeding disorders of unknown cause
The role of antifactor Xa monitoring in the dosing and administration of low-molecular-weight heparins in pregnancy: a systematic review and meta-analysis
Mathematical modeling of flow-mediated thrombin generation after treatment of postoperative bleeding in cardiac surgery with cardiopulmonary bypass
Plasma protein profile in patients with antiphospholipid syndrome and controls without antiphospholipid syndrome
Preserving expertise in vitamin K antagonists in the era of direct oral anticoagulants: avoiding therapeutic segregation
Frailty assessment in people with hemophilia
Successful immune tolerance induction using efanesoctocog alfa in severe hemophilia A: a case series
Pretest direct oral anticoagulant removal is highly effective in lupus anticoagulant testing while on direct oral anticoagulants: a real-life experience
EUVIMED